BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 22871495)

  • 1. The putative tumor suppressor miR-524-5p directly targets Jagged-1 and Hes-1 in glioma.
    Chen L; Zhang W; Yan W; Han L; Zhang K; Shi Z; Zhang J; Wang Y; Li Y; Yu S; Pu P; Jiang C; Jiang T; Kang C
    Carcinogenesis; 2012 Nov; 33(11):2276-82. PubMed ID: 22871495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant T cell expression of Ca2+ influx-regulated miRNAs in patients with systemic lupus erythematosus promotes lupus pathogenesis.
    Lu MC; Yu CL; Chen HC; Yu HC; Huang HB; Lai NS
    Rheumatology (Oxford); 2015 Feb; 54(2):343-8. PubMed ID: 25172935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jagged-1-HES-1 signaling inhibits the differentiation of TH17 cells via ROR gammat.
    You P; Xing F; Mao C; Chen Z; Zhang H; Wang Y; Xu J; Di J; Zeng S; Liu J
    J Biol Regul Homeost Agents; 2013; 27(1):79-93. PubMed ID: 23489689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jagged1 regulates the activation of astrocytes via modulation of NFkappaB and JAK/STAT/SOCS pathways.
    Morga E; Mouad-Amazzal L; Felten P; Heurtaux T; Moro M; Michelucci A; Gabel S; Grandbarbe L; Heuschling P
    Glia; 2009 Dec; 57(16):1741-53. PubMed ID: 19455581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells.
    Harrington LS; Sainson RC; Williams CK; Taylor JM; Shi W; Li JL; Harris AL
    Microvasc Res; 2008 Mar; 75(2):144-54. PubMed ID: 17692341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Jagged-1/Notch-1/Hes-1 pathway is involved in intestinal adaptation in a massive small bowel resection rat model.
    Chen G; Sun L; Yu M; Meng D; Wang W; Yang Y; Yang H
    Dig Dis Sci; 2013 Sep; 58(9):2478-86. PubMed ID: 23595520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuralized1 causes apoptosis and downregulates Notch target genes in medulloblastoma.
    Teider N; Scott DK; Neiss A; Weeraratne SD; Amani VM; Wang Y; Marquez VE; Cho YJ; Pomeroy SL
    Neuro Oncol; 2010 Dec; 12(12):1244-56. PubMed ID: 20847082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation.
    Purow BW; Haque RM; Noel MW; Su Q; Burdick MJ; Lee J; Sundaresan T; Pastorino S; Park JK; Mikolaenko I; Maric D; Eberhart CG; Fine HA
    Cancer Res; 2005 Mar; 65(6):2353-63. PubMed ID: 15781650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study on Notch signaling in human breast cancer.
    Zang S; Ji Ch; Qu X; Dong X; Ma D; Ye J; Ma R; Dai J; Guo D
    Neoplasma; 2007; 54(4):304-10. PubMed ID: 17822320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1.
    Tu Y; Gao X; Li G; Fu H; Cui D; Liu H; Jin W; Zhang Y
    Cancer Res; 2013 Oct; 73(19):6046-55. PubMed ID: 23950210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions.
    Fang KM; Lin TC; Chan TC; Ma SZ; Tzou BC; Chang WR; Liu JJ; Chiou SH; Yang CS; Tzeng SF
    Glia; 2013 Sep; 61(9):1402-17. PubMed ID: 23832679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation.
    Delic S; Lottmann N; Stelzl A; Liesenberg F; Wolter M; Götze S; Zapatka M; Shiio Y; Sabel MC; Felsberg J; Reifenberger G; Riemenschneider MJ
    Neuro Oncol; 2014 Jan; 16(2):179-90. PubMed ID: 24305703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch1 signaling in FIZZ1 induction of myofibroblast differentiation.
    Liu T; Hu B; Choi YY; Chung M; Ullenbruch M; Yu H; Lowe JB; Phan SH
    Am J Pathol; 2009 May; 174(5):1745-55. PubMed ID: 19349363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notch-Hes1 pathway contributes to the cochlear prosensory formation potentially through the transcriptional down-regulation of p27Kip1.
    Murata J; Ohtsuka T; Tokunaga A; Nishiike S; Inohara H; Okano H; Kageyama R
    J Neurosci Res; 2009 Dec; 87(16):3521-34. PubMed ID: 19598246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of miR-210 decreases hypoxic glioma stem cells stemness and radioresistance.
    Yang W; Wei J; Guo T; Shen Y; Liu F
    Exp Cell Res; 2014 Aug; 326(1):22-35. PubMed ID: 24930954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-584-3p, a novel tumor suppressor and prognostic marker, reduces the migration and invasion of human glioma cells by targeting hypoxia-induced ROCK1.
    Xue H; Guo X; Han X; Yan S; Zhang J; Xu S; Li T; Guo X; Zhang P; Gao X; Liu Q; Li G
    Oncotarget; 2016 Jan; 7(4):4785-805. PubMed ID: 26715733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-656 inhibits glioma tumorigenesis through repression of BMPR1A.
    Guo M; Jiang Z; Zhang X; Lu D; Ha AD; Sun J; Du W; Wu Z; Hu L; Khadarian K; Shen J; Lin Z
    Carcinogenesis; 2014 Aug; 35(8):1698-706. PubMed ID: 24480809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of Hes-1, a downstream target of notch signaling in hepatocellular carcinoma.
    Zou JH; Xue TC; Sun C; Li Y; Liu BB; Sun RX; Chen J; Ren ZG; Ye SL
    Asian Pac J Cancer Prev; 2015; 16(9):3811-6. PubMed ID: 25987042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
    Conti A; Romeo SG; Cama A; La Torre D; Barresi V; Pezzino G; Tomasello C; Cardali S; Angileri FF; Polito F; Ferlazzo G; Di Giorgio R; Germanò A; Aguennouz M
    Tumour Biol; 2016 Oct; 37(10):14035-14048. PubMed ID: 27495233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas.
    Liu J; Xu J; Li H; Sun C; Yu L; Li Y; Shi C; Zhou X; Bian X; Ping Y; Wen Y; Zhao S; Xu H; Ren L; An T; Wang Q; Yu S
    Oncotarget; 2015 Oct; 6(30):29129-42. PubMed ID: 26320176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.